High Nasopharyngeal SARS-CoV-2 Load and Delayed Clearance in Hospitalized Patients With Blood Autoantibodies Neutralizing Type I Interferons

Autoantibodies neutralizing type I interferon (AAN-I-IFNs) underlie life-threatening COVID-19. In hospitalized COVID-19 patients of the DisCoVeRy trial (NCT-04315948), AAN-I-IFNs were associated with higher nasopharyngeal viral load at inclusion (P = 1.4 × 10-3) and delayed viral clearance (P = .013). Blood AAN-I-IFNs, high viral load and delayed clearance were also independent risk factors for critical COVID-19.

Authors

Institutions

Publication Details

Journal
The Journal of Infectious Diseases
Published
2026-04-24
DOI
https://doi.org/10.1093/infdis/jiag172
Primary Topic
COVID-19 Clinical Research Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

High Nasopharyngeal SARS-CoV-2 Load and Delayed Clearance in Hospitalized Patients With Blood Autoantibodies Neutralizing Type I Interferons

Charles‐Hugo Marquette, Antoine Altdorfer, Clément Massonnaud, Mathieu Blot et al.
The Journal of Infectious Diseases
COVID-19 Clinical Research Studies
article

High Nasopharyngeal SARS-CoV-2 Load and Delayed Clearance in Hospitalized Patients With Blood Autoantibodies Neutralizing Type I Interferons

Charles‐Hugo Marquette, Antoine Altdorfer, Clément Massonnaud, Mathieu Blot, Paul Bastard, Guillaume Lingas, Nadia Saïdani, Gil Verschelden, Vincent Piriou, Jean-Christophe Navellou, Alexandre Duvignaud, P Loubet, Jean‐Philippe Lanoix, Emmanuel Faure, Agathe Delbove, Alexandre Gaymard, Nicolas Terzi, Yoann Zerbib, Vincent Fraipont, Jean Dellamonica, Adrian Gervais, France Mentré, Johan Courjon, J Reignier, David Bougon, Sébastien Gibot, Alexander Egle, Richard Greil, Antoine Kimmoun, Lucy Bizien, Bernd Lamprecht, Didier Gruson, Olivier Épaulard, O. Hinschberger, H Esperou, Maya Hites, Florence Ader, Anne Puel, Céline Robert, Saad Nseir, C. Roger, Henry Lessire, M Joannidis, Pierre-Alexandre Roger, Guilhem Wattecamps, Astrid Marchal, Kada Klouche, Cyrille Chabartier, Rostane Gaci, Julien Textoris, Paul Le Turnier, Thibault Kerdiles, A Makinson, Joy Mootien, Julie Bertrand, Violaine Tolsma, Laurent Argaud, Pascal Andreu, V Le Moing, J Poissy, F Goehringer, Charles Cazanave, F Valour, Jean Pierre QUENOT, Benjamin Gaborit, K Bouiller, B Lefèvre, C Delmas, Florent Wallet, Aglaé Perrin, Aurélie Cobat, Laurent Abel, Jean-Laurent Casanova, Maude Bouscambert-Duchamp, Nathan Peiffer-Smadja, Jérémie Guedj, Karine Faure, Martin Martinot, Claire Andrejak, Sylvie Leroy, the DisCoVeRy Study Group, François Raffi, Emmanuel Canet, Tristan Ferry, André Cabié, Jean-Marie Turmel, Sandrine Couffin-Cadièrgues, Catherine Chirouze, Denis Malvy, Loïc Epelboin, Jean-Christophe Richard, Félix Djossou, Leila Belkhir, David Boutoille, Alexandre Boyer, Thomas Perpoint, Marie Gousseff, Lionel Piroth
article en

Abstract

Autoantibodies neutralizing type I interferon (AAN-I-IFNs) underlie life-threatening COVID-19. In hospitalized COVID-19 patients of the DisCoVeRy trial (NCT-04315948), AAN-I-IFNs were associated with higher nasopharyngeal viral load at inclusion (P = 1.4 × 10-3) and delayed viral clearance (P = .013). Blood AAN-I-IFNs, high viral load and delayed clearance were also independent risk factors for critical COVID-19.

The Journal of Infectious Diseases
Université Claude Bernard Lyon 1 (FR), École Normale Supérieure de Lyon (FR), Centre National de la Recherche Scientifique (FR), Université Libre de Bruxelles (BE), Howard Hughes Medical Institute (US), Inserm (FR), Université Paris Cité (FR), Hospital for Sick Children (CA), National Institute for Health and Care Research (GB), Sorbonne Université (FR), Institut Necker Enfants Malades (FR), Hospital for Sick Children Pediatric Center (US), Université Sorbonne Paris Nord (FR), Sorbonne Paris Cité (FR), Assistance Publique – Hôpitaux de Paris (FR), Hospices Civils de Lyon (FR), Centre Hospitalier Universitaire Brugmann (BE), Institut de Biologie Paris-Seine (FR), Hôpital Lariboisière (FR), Hôpital Bichat-Claude-Bernard (FR), Institut des Maladies Génétiques Imagine (FR), Imperial College London (GB), Université Paris 1 Panthéon-Sorbonne (FR), Rockefeller University (US)
Howard Hughes Medical Institute, Fisher Center for Alzheimer's Research Foundation, St. Giles Foundation, Meyer Foundation, JPB Foundation, Ministry of Health, Rockefeller University, Fondation du Souffle, Institut des maladies génétiques Imagine, SCOR Corporate Foundation for Science, European Commission, Agence Nationale de la Recherche, Institut National de la Santé et de la Recherche Médicale, Fondation pour la Recherche Médicale, Stavros Niarchos Foundation, Ministère de l'Enseignement Supérieur et de la Recherche, Université Libre de Bruxelles, National Institutes of Health, Horizon 2020, European Regional Development Fund, Belgian Health Care Knowledge Centre, National Center for Advancing Translational Sciences
Openalex Percentile: Top 8%
COVID-19 Clinical Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.